BioNTech completes mid-stage trial for COVID-19 shot in China (NASDAQ:BNTX) | Seeking Alpha

Retrieved on: 2022-05-10 19:29:33

Tags for this article:

Click the tags to see associated articles and topics

BioNTech completes mid-stage trial for COVID-19 shot in China (NASDAQ:BNTX) | Seeking Alpha. View article details on hiswai:

Excerpt

German vaccine developer, BioNTech (BNTX) has completed a Phase 2 study for the company's blockbuster COVID-19 vaccine in China in January, ...

Article found on: seekingalpha.com